These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 17707537)
41. MLPA screening in the BRCA1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases. Engert S; Wappenschmidt B; Betz B; Kast K; Kutsche M; Hellebrand H; Goecke TO; Kiechle M; Niederacher D; Schmutzler RK; Meindl A Hum Mutat; 2008 Jul; 29(7):948-58. PubMed ID: 18431737 [TBL] [Abstract][Full Text] [Related]
42. Mammary tumor development in dogs is associated with BRCA1 and BRCA2. Rivera P; Melin M; Biagi T; Fall T; Häggström J; Lindblad-Toh K; von Euler H Cancer Res; 2009 Nov; 69(22):8770-4. PubMed ID: 19887619 [TBL] [Abstract][Full Text] [Related]
43. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study. Lee E; Ma H; McKean-Cowdin R; Van Den Berg D; Bernstein L; Henderson BE; Ursin G Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3170-8. PubMed ID: 18990759 [TBL] [Abstract][Full Text] [Related]
44. Polymorphism of the homologous recombination repair genes RAD51 and XRCC3 in breast cancer. Krupa R; Synowiec E; Pawlowska E; Morawiec Z; Sobczuk A; Zadrozny M; Wozniak K; Blasiak J Exp Mol Pathol; 2009 Aug; 87(1):32-5. PubMed ID: 19426727 [TBL] [Abstract][Full Text] [Related]
45. Radiotherapy for breast cancer. Kunkler I N Engl J Med; 2002 Mar; 346(11):862-4. PubMed ID: 11898812 [No Abstract] [Full Text] [Related]
46. BRCA1 and BRCA2 heterozygosity in embryonic stem cells reduces radiation-induced Rad51 focus formation but is not associated with radiosensitivity. Sioftanos G; Ismail A; Föhse L; Shanley S; Worku M; Short SC Int J Radiat Biol; 2010 Dec; 86(12):1095-105. PubMed ID: 20979543 [TBL] [Abstract][Full Text] [Related]
47. Penetrance of BRCA1/BRCA2 specific gene mutations in Iranian women with breast cancer. Hashemian AH; Hajizadeh E; Kazemnejad A; Atri M; Mehdipour P Saudi Med J; 2009 Jan; 30(1):41-4. PubMed ID: 19139771 [TBL] [Abstract][Full Text] [Related]
48. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA; J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327 [TBL] [Abstract][Full Text] [Related]
49. Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families. Hansen Tv; Jønson L; Albrechtsen A; Andersen MK; Ejlertsen B; Nielsen FC Breast Cancer Res Treat; 2009 May; 115(2):315-23. PubMed ID: 18546071 [TBL] [Abstract][Full Text] [Related]
50. BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model. Vogel KJ; Atchley DP; Erlichman J; Broglio KR; Ready KJ; Valero V; Amos CI; Hortobagyi GN; Lu KH; Arun B J Clin Oncol; 2007 Oct; 25(29):4635-41. PubMed ID: 17925560 [TBL] [Abstract][Full Text] [Related]
51. The molecular pathology of hereditary breast cancer. Palacios J; Robles-Frías MJ; Castilla MA; López-García MA; Benítez J Pathobiology; 2008; 75(2):85-94. PubMed ID: 18544963 [TBL] [Abstract][Full Text] [Related]
52. A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers. Kadouri L; Kote-Jarai Z; Hubert A; Durocher F; Abeliovich D; Glaser B; Hamburger T; Eeles RA; Peretz T Br J Cancer; 2004 May; 90(10):2002-5. PubMed ID: 15138485 [TBL] [Abstract][Full Text] [Related]
53. Simultaneous ATM/BRCA1/RAD51 expression variations associated with prognostic factors in Iranian sporadic breast cancer patients. Hallajian Z; Mahjoubi F; Nafissi N Breast Cancer; 2017 Jul; 24(4):624-634. PubMed ID: 28058614 [TBL] [Abstract][Full Text] [Related]
54. Genetic susceptibility for breast cancer: how many more genes to be found? Oldenburg RA; Meijers-Heijboer H; Cornelisse CJ; Devilee P Crit Rev Oncol Hematol; 2007 Aug; 63(2):125-49. PubMed ID: 17498966 [TBL] [Abstract][Full Text] [Related]
55. The carboxyl-terminal of BRCA1 is required for subnuclear assembly of RAD51 after treatment with cisplatin but not ionizing radiation in human breast and ovarian cancer cells. Zhou C; Huang P; Liu J Biochem Biophys Res Commun; 2005 Oct; 336(3):952-60. PubMed ID: 16165098 [TBL] [Abstract][Full Text] [Related]
56. Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers. Connell PP; Jayathilaka K; Haraf DJ; Weichselbaum RR; Vokes EE; Lingen MW Int J Oncol; 2006 May; 28(5):1113-9. PubMed ID: 16596227 [TBL] [Abstract][Full Text] [Related]
57. Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells. Yuan R; Fan S; Wang JA; Meng Q; Ma Y; Schreiber D; Goldberg ID; Rosen EM Prostate; 1999 Jun; 40(1):37-49. PubMed ID: 10344722 [TBL] [Abstract][Full Text] [Related]
58. [Gene expression profiles in hereditary breast cancer]. Sack H Strahlenther Onkol; 2001 Oct; 177(10):559-60. PubMed ID: 11680024 [No Abstract] [Full Text] [Related]
59. Distinct functions of BRCA1 and BRCA2 in double-strand break repair. Liu Y; West SC Breast Cancer Res; 2002; 4(1):9-13. PubMed ID: 11879553 [TBL] [Abstract][Full Text] [Related]